Next Article in Journal
Biomass Thermogravimetric Analysis: Uncertainty Determination Methodology and Sampling Maps Generation
Previous Article in Journal
Principal Component Analysis of HPLC Retention Data and Molecular Modeling Structural Parameters of Cardiovascular System Drugs in View of Their Pharmacological Activity
Previous Article in Special Issue
Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders
This is an addendum to Int. J. Mol. Sci. 2010, 11(6), 2566-2575.

Int. J. Mol. Sci. 2010, 11(7), 2699-2700; doi:10.3390/ijms11072699
Addendum

Addendum: Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575

1,2,* , 3
 and
1,2
Received: 5 July 2010 / Accepted: 8 July 2010 / Published: 12 July 2010
View Full-Text   |   Download PDF [23 KB, uploaded 19 June 2014]

Abstract

One additional skin lightening or whitening quasi-drug (QD) has been developed and officially approved by the Ministry of Health, Labor and Welfare of Japan.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Ando, H.; Matsui, M.S.; Ichihashi, M. Addendum: Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders. Int. J. Mol. Sci. 2010, 11, 2566–2575. Int. J. Mol. Sci. 2010, 11, 2699-2700.

View more citation formats

Related Articles

Article Metrics

Comments

Citing Articles

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert